{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/08/11/3342646/0/en/mereo-biopharma-and-sentynl-therapeutics-announce-option-and-license-agreement-for-alvelestat-in-alpha-1-antitrypsin-deficiency-associated-lung-disease-aatd-ld.html", "message": "News view counter 875135 successfully enlarged"}